Design (Testphase)
Quality & Balance Sheet
Mike Webster: Recession Proof
25
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Webster's recession screen (original 2020 formula): revenue growth in the latest quarter ≥ 25% AND averaging ≥ 25% over the last 6 quarters, plus relative strength across all timeframes (RS rating, 3-month RS, and 6-month RS each ≥ 80), price ≥ $10, and average dollar volume ≥ $20M. Webster's logic: 'Revenue growth carries you through a recession' — hence revenue instead of earnings, plus heavy RS. Source: fundamental data.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MXL MaxLinear Inc | 07/22 | +69 % | 72 7/25 | Stage 2 | B 64 | 4 of 9 | 6.0 $ | Semiconductors | Sells AI | — | Technology | 66.80 $ | +411.1 % | +518.4 % | +322.4 % | −11.1 % | +41.5 % | 99 | 8 | 10.9 % | 11.9 % | 3.93 | — | 38.5 | 10.5 | 11.9 | 1,813.6 | 0.39 | 12.3 | -12.2 % | 57.5 % | -18.2 % | -27.9 % | -4.9 % | 0.33 | 58.9 % | +29.7 % | — | 0.0 % | 0.0 % | 2.4 | 87.4 % | 6.0 % | 4.2 (11) | |
| AAOI Applied Optoelectronics, Inc. | 08/06 | +1,099 % | 92 10/25 | Stage 2 | B 62 | 4 of 9 | 7.6 $ | Communication Equipment | Sells AI | — | — | Technology | 94.30 $ | +322.9 % | +266.1 % | +312.4 % | −40.7 % | +59.4 % | 98 | 42 | 12.0 % | 12.7 % | 3.69 | — | 84.0 | 14.9 | 6.9 | — | 0.78 | 38.4 | -8.6 % | 29.6 % | -8.6 % | -6.1 % | -3.3 % | 0.16 | 70.6 % | +82.8 % | — | 0.0 % | 0.0 % | 7.6 | 68.3 % | 12.9 % | 4.2 (5) |
| AIP Arteris Inc | 08/04 | +177 % | 61 6/25 | Stage 2 | C 48 | 3 of 9 | 1.4 $ | Semiconductors | Sells AI | — | — | Technology | 29.90 $ | +165.9 % | +197.1 % | +203.0 % | −3.8 % | +27.8 % | 98 | 42 | 7.1 % | 7.5 % | 1.92 | — | 0.0 | 18.4 | 501.5 | — | — | -7.7 | -38.0 % | 88.8 % | -44.9 % | -1,369.6 % | -17.9 % | 2.11 | 1.8 % | +22.3 % | — | 0.0 % | 0.0 % | -3.7 | 61.1 % | 7.3 % | 4.5 (4) |
| STRL Sterling Construction Company Inc | 08/03 | +532 % | 48 6/29 | Stage 2 | A 82 | 7 of 9 | 19.1 $ | Engineering & Construction | Uses AI | — | — | Industrials | 596.80 $ | +191.4 % | +159.2 % | +123.0 % | −12.3 % | +58.6 % | 97 | 88 | 7.1 % | 7.5 % | 1.83 | 48.7 | 31.6 | 6.6 | 14.0 | 43.5 | 1.02 | 30.8 | 17.2 % | 23.3 % | 12.0 % | 36.7 % | 12.9 % | 0.57 | 42.7 % | +17.7 % | — | 0.0 % | 0.0 % | 6.7 | 95.7 % | 4.8 % | 5.0 (3) |
| CRDO Credo Technology Group Holding Ltd | 09/02 | +487 % | 72 7/25 | Stage 2 | A 87 | 7 of 9 | 38.5 $ | Semiconductors | Sells AI | — | Technology | 207.00 $ | +89.0 % | +63.6 % | +85.6 % | −13.2 % | +34.9 % | 96 | 93 | 10.5 % | 11.3 % | 3.20 | 83.7 | 35.1 | 28.8 | 18.8 | 94.6 | — | 77.5 | 35.7 % | 68.0 % | 35.4 % | 34.4 % | 17.9 % | 0.01 | 89.9 % | +205.7 % | — | 0.0 % | 0.0 % | 19.7 | 75.9 % | 3.6 % | 4.6 (13) | |
| TVTX Travere Therapeutics Inc | 08/05 | +82 % | 68 6/22 | Stage 2 | B 64 | 5 of 9 | 5.1 $ | Biotechnology | Uses AI | — | Healthcare | 55.90 $ | +46.4 % | +44.7 % | +261.8 % | −1.8 % | +5.8 % | 96 | 42 | 3.6 % | 4.6 % | 1.11 | — | 76.3 | 9.5 | 51.5 | 292.4 | — | 136.5 | -29.0 % | 56.0 % | -4.0 % | -69.4 % | -6.5 % | 3.35 | 17.8 % | +110.5 % | — | 0.0 % | 0.0 % | -2.7 | 113.4 % | 16.9 % | 4.6 (15) | |
| SITM Sitime Corporation | 08/05 | +172 % | 72 7/25 | Stage 2 | A 77 | 7 of 9 | 15.1 $ | Semiconductors | Sells AI | — | — | Technology | 535.20 $ | +100.1 % | +87.9 % | +163.8 % | −25.1 % | +56.5 % | 95 | 12 | 8.0 % | 7.5 % | 2.91 | — | 71.9 | 39.6 | 12.1 | 278.7 | 3.82 | 3,076.2 | -4.2 % | 55.7 % | -6.4 % | -2.6 % | -2.3 % | 0.00 | 89.6 % | +61.2 % | — | 0.0 % | 0.0 % | 16.1 | 89.0 % | 5.0 % | 3.9 (7) |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B 64 | 7 of 9 | 9.0 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 31.20 $ | +108.3 % | +97.3 % | +122.2 % | −5.6 % | -19.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.7 | 5.7 | 3.2 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | — | 0.0 % | 0.0 % | 3.0 | 67.6 % | 8.0 % | 3.3 (7) |
| XMTR Xometry Inc | 08/04 | +114 % | 66 8/29 | Stage 2 | B 65 | 5 of 9 | 4.7 $ | Industrial Distribution | – | — | — | Industrials | 85.70 $ | +54.3 % | +48.6 % | +165.1 % | −7.3 % | +12.3 % | 94 | 42 | 4.8 % | 5.7 % | 1.27 | — | 111.1 | 6.4 | 16.6 | — | — | -13.1 | -2.5 % | 39.3 % | -7.0 % | -17.5 % | -3.1 % | 1.21 | 38.1 % | +25.9 % | — | 0.0 % | 0.0 % | 3.0 | 96.4 % | 7.0 % | 3.9 (10) |
| URGN UroGen Pharma Ltd | 08/06 | +18 % | 69 6/22 | Stage 2 | B 57 | 3 of 9 | 1.8 $ | Biotechnology | Uses AI | — | — | Healthcare | 38.20 $ | +50.1 % | +51.8 % | +100.6 % | −4.7 % | +17.1 % | 94 | 42 | 5.1 % | 5.4 % | 1.58 | — | 0.0 | 13.1 | — | — | — | -2.6 | -39.8 % | 89.9 % | -94.8 % | -1,481.3 % | -27.0 % | — | -49.0 % | +21.5 % | — | 0.0 % | 0.0 % | -8.0 | 100.6 % | 11.9 % | 4.4 (8) |
| RKLB Rocket Lab USA Inc. | 08/06 | +539 % | 66 8/29 | Stage 2 | B 63 | 4 of 9 | 41.7 $ | Aerospace & Defense | – | — | — | Industrials | 65.00 $ | +36.4 % | +27.0 % | +41.4 % | −46.6 % | +76.1 % | 93 | 42 | 8.8 % | 9.5 % | 2.55 | — | 0.0 | 61.4 | 19.0 | — | — | -16.4 | -22.4 % | 36.6 % | -26.9 % | -13.6 % | -6.6 % | 0.07 | 80.3 % | +38.0 % | — | 0.0 % | 0.0 % | 9.1 | 59.0 % | 8.0 % | 4.1 (15) |
| OUST Ouster, Inc. Common Stock | 08/06 | +244 % | 61 6/25 | Stage 2 | B 58 | 6 of 9 | 2.6 $ | Electronic Components | Sells AI | — | Technology | 39.00 $ | +108.7 % | +141.8 % | +66.9 % | −18.8 % | +33.7 % | 93 | 42 | 15.3 % | 13.5 % | 3.18 | — | 0.0 | 14.2 | — | — | — | -0.8 | -39.6 % | 47.7 % | -30.1 % | -25.2 % | -14.7 % | — | 72.2 % | +52.5 % | — | 0.0 % | 0.0 % | -0.7 | 50.0 % | 9.3 % | 4.3 (6) | |
| AXSM Axsome Therapeutics Inc | 08/03 | +58 % | 78 7/22 | Stage 2 | B 55 | 5 of 9 | 11.6 $ | Biotechnology | – | — | — | Healthcare | 218.00 $ | +32.5 % | +56.9 % | +115.0 % | −8.8 % | +29.5 % | 92 | 42 | 3.6 % | 3.5 % | 0.60 | — | 333.3 | 16.3 | 205.5 | — | — | -14.8 | -32.8 % | 92.6 % | -26.6 % | -349.4 % | -16.8 % | 4.03 | 7.6 % | +65.6 % | — | 0.0 % | 0.0 % | -3.1 | 76.6 % | 9.2 % | 4.7 (19) |
| MRX Marex Group plc Ordinary Shares | 08/12 | — | 79 7/22 | Stage 2 | B 61 | 4 of 9 | 4.6 $ | Capital Markets | – | — | — | Financial Services | 64.90 $ | +74.6 % | +49.3 % | +70.9 % | −4.8 % | +11.5 % | 92 | 79 | 4.9 % | 4.7 % | -0.09 | 14.7 | 8.8 | 0.8 | 3.5 | — | — | 6.1 | 13.1 % | 68.9 % | 10.6 % | 29.1 % | 1.1 % | — | 3.7 % | +25.4 % | — | 1.0 % | 17.1 % | 4.2 | 75.2 % | 5.1 % | 4.3 (8) |
| UMAC Unusual Machines, Inc. | 08/13 | — | 83 8/25 | Stage 2 | C 52 | 3 of 9 | 1.0 $ | Computer Hardware | Neutral | — | Technology | 21.20 $ | +56.4 % | +30.8 % | +129.0 % | −40.4 % | +64.4 % | 92 | 42 | 10.2 % | 15.0 % | 14.79 | — | 67.6 | 60.9 | 3.0 | — | — | 0.0 | -89.7 % | 35.2 % | -32.7 % | -3.3 % | -10.2 % | 0.00 | 95.8 % | +101.2 % | — | 0.0 % | 0.0 % | 76.3 | 60.2 % | 19.7 % | 4.7 (3) | |
| KRYS Krystal Biotech Inc | 08/03 | +62 % | 53 5/22 | Stage 2 | A 80 | 7 of 9 | 10.2 $ | Biotechnology | Uses AI | — | — | Healthcare | 341.10 $ | +38.0 % | +50.5 % | +121.7 % | −0.7 % | +12.7 % | 91 | 78 | 4.2 % | 3.9 % | 0.50 | 46.7 | 45.0 | 24.4 | 7.9 | 42.9 | — | 49.9 | 46.1 % | 94.2 % | 53.9 % | 19.9 % | 9.0 % | 0.01 | 91.4 % | +33.9 % | — | 0.0 % | 0.0 % | 19.8 | 99.4 % | 19.5 % | 4.6 (11) |
| SEZL Sezzle Inc. | 08/06 | — | 70 6/22 | Stage 2 | A 76 | 6 of 9 | 5.4 $ | Credit Services | Uses AI | — | Financial Services | 154.80 $ | +138.8 % | +131.8 % | -0.1 % | −12.3 % | +5.7 % | 91 | 76 | 8.0 % | 7.4 % | 6.72 | 22.2 | 30.3 | 11.2 | 15.9 | 22.5 | 0.11 | 28.5 | 61.0 % | 74.3 % | 30.8 % | 92.0 % | 47.5 % | 0.74 | 43.3 % | +66.1 % | — | 0.0 % | 0.0 % | 11.4 | 40.9 % | 23.2 % | 5.0 (2) | |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 53 5/22 | Stage 2 | B 68 | 5 of 9 | 8.0 $ | Biotechnology | Neutral | — | Healthcare | 52.00 $ | +80.9 % | +79.3 % | +46.6 % | −6.5 % | +31.6 % | 90 | 92 | 5.0 % | 4.8 % | 1.60 | 18.9 | 55.2 | 11.5 | 14.2 | — | 1.61 | 54.6 | 17.0 % | 83.1 % | 66.0 % | 112.6 % | 8.6 % | 1.29 | 38.1 % | +87.3 % | — | 0.0 % | 0.0 % | 6.2 | 70.2 % | 29.0 % | 4.3 (9) | |
| NVT nVent Electric PLC | 08/07 | +87 % | 66 8/29 | Stage 2 | B 68 | 5 of 9 | 24.9 $ | Electrical Equipment & Parts | – | — | — | Industrials | 153.80 $ | +65.7 % | +57.6 % | +97.5 % | −6.9 % | +26.5 % | 90 | 12 | 5.1 % | 4.9 % | 1.36 | 49.6 | 35.0 | 5.2 | 6.2 | 43.1 | 1.62 | 24.6 | 16.0 % | 37.0 % | 12.4 % | 13.0 % | 7.6 % | 1.51 | 54.5 % | +29.5 % | — | 0.6 % | 19.1 % | 6.7 | 95.9 % | 2.8 % | 4.5 (13) |
| BTDR Bitdeer Technologies Group | 08/17 | +17 % | 73 7/25 | Stage 3 | B 62 | 3 of 9 | 2.6 $ | Software - Application | Sells AI | — | Technology | 10.50 $ | +53.7 % | +38.0 % | -18.4 % | −41.0 % | +113.3 % | 89 | 42 | 10.6 % | 10.4 % | 2.47 | — | 1,000.0 | 3.5 | 3.7 | — | — | 13.2 | -43.4 % | 3.5 % | -27.0 % | -26.1 % | 6.2 % | 2.78 | 23.5 % | +77.3 % | — | 0.0 % | 0.0 % | 4.7 | 70.9 % | 36.8 % | 4.7 (12) | |
| VIRT Virtu Financial, Inc. | 07/29 | +98 % | 96 10/22 | Stage 2 | B 55 | 3 of 9 | 12.6 $ | Capital Markets | – | — | — | Financial Services | 58.70 $ | +92.3 % | +74.0 % | +36.2 % | −5.9 % | +13.7 % | 89 | 83 | 4.6 % | 3.8 % | 0.58 | 9.7 | 9.8 | 3.1 | 2.9 | 26.1 | — | 6.4 | 46.8 % | 65.8 % | 16.9 % | 56.9 % | 4.5 % | 2.68 | 6.9 % | +26.3 % | — | 1.6 % | 14.6 % | 4.7 | 92.4 % | 5.8 % | 3.3 (9) |
| ASTH Astrana Health Inc | 08/06 | +13 % | 70 6/22 | Stage 2 | B 62 | 5 of 9 | 1.8 $ | Medical Care Facilities | Uses AI | — | Healthcare | 35.60 $ | +66.1 % | +79.3 % | +49.0 % | −0.5 % | +38.6 % | 89 | 87 | 3.6 % | 3.8 % | 0.89 | — | 23.0 | 0.5 | — | 11.4 | — | 14.4 | 3.0 % | 10.7 % | 0.9 % | 5.7 % | 3.6 % | — | 33.9 % | +56.4 % | — | 0.0 % | 0.0 % | 5.2 | 61.5 % | 10.3 % | 4.5 (12) | |
| RSI Rush Street Interactive Inc | 07/29 | +294 % | 51 7/31 | Stage 2 | B 71 | 6 of 9 | 6.4 $ | Gambling | Uses AI | — | Consumer Cyclical | 26.90 $ | +51.9 % | +63.0 % | +33.5 % | −2.2 % | +33.8 % | 86 | 81 | 4.7 % | 4.0 % | 1.56 | 77.7 | 43.5 | 4.7 | 17.1 | 37.7 | — | 13.6 | 11.6 % | 35.0 % | 2.3 % | 34.7 % | 12.8 % | 0.04 | 23.5 % | +22.8 % | — | 0.0 % | 0.0 % | 5.4 | 100.5 % | 9.6 % | 4.9 (7) | |
| DAVE Dave Inc | 08/05 | +2,117 % | 61 6/25 | Stage 2 | A 84 | 6 of 9 | 4.7 $ | Software - Application | Uses AI | — | Technology | 372.70 $ | +43.6 % | +62.5 % | +58.1 % | −5.8 % | +4.5 % | 83 | 86 | 8.5 % | 8.1 % | 3.83 | — | 22.7 | 7.8 | — | 14.4 | — | 22.1 | 38.3 % | 72.1 % | 37.2 % | 111.6 % | 32.0 % | — | 38.4 % | +59.7 % | — | 0.0 % | 0.0 % | 11.6 | 100.1 % | 21.0 % | 4.8 (8) | |
| AEVA Aeva Technologies, Inc. | 07/30 | +100 % | 80 8/25 | Stage 2 | C 50 | 5 of 9 | 1.3 $ | Software - Infrastructure | – | — | — | Technology | 17.50 $ | +77.3 % | +90.3 % | -5.9 % | −48.1 % | +43.6 % | 81 | 42 | 12.5 % | 12.1 % | 2.40 | — | 0.0 | 60.6 | 68.6 | — | — | -0.1 | — | 4.6 % | 0.0 % | -516.1 % | -63.2 % | -8.22 | — | +99.4 % | — | 0.0 % | 0.0 % | -16.8 | 66.1 % | 10.2 % | 4.4 (5) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Webster's recession screen (original 2020 formula): revenue growth in the latest quarter ≥ 25% AND averaging ≥ 25% over the last 6 quarters, plus relative strength across all timeframes (RS rating, 3-month RS, and 6-month RS each ≥ 80), price ≥ $10, and average dollar volume ≥ $20M. Webster's logic: 'Revenue growth carries you through a recession' — hence revenue instead of earnings, plus heavy RS.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 25 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- Altman Z: Balance Sheet Fortress
- Buffett Criteria (Buffettology)
- Buffett: Owner Earnings Yield
- CEO Buys
- FCF/Market Cap
- Fundamental Rank (A / A+)
- Insider Buying (Net)
- Institutional + Insiders Building Positions
- Institutional Accumulation
- Institutions + CEO Buying
- Levermann
- Mark Minervini Code 33
- Piotroski F-Score (7–9)
- Pros 80%
- QARP — Quality at a Fair Price
- Terry Smith: Quality (Fundsmith Criteria)
- U/D Accumulation
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.